News & Updates
Filter by Specialty:

Prolonged-release pirfenidone shows therapeutic potential in post–COVID-19 pulmonary fibrosis
A 3-month course of prolonged-release pirfenidone formulation appears to be safe and efficacious in the treatment of patients with postacute sequelae of COVID-19 (PASC)-pulmonary fibrosis, as shown in a study.
Prolonged-release pirfenidone shows therapeutic potential in post–COVID-19 pulmonary fibrosis
22 Jul 2023
Metabolic surgery bests medical/lifestyle management for people with diabetes in the long run
Individuals with type 2 diabetes (T2D) may fare better with metabolic bariatric surgery, which confers more favourable long-term outcomes as compared with intensive medical and lifestyle management, based on the 7- and 12-year data from the ARMMS-T2D* trial.
Metabolic surgery bests medical/lifestyle management for people with diabetes in the long run
21 Jul 2023
Age, tumour size predict post-TACE complications in HCC patients
In patients with hepatocellular carcinoma (HCC), most complications following transarterial chemoembolization (TACE) involve minor postembolization syndrome, reveals a study presented at EASL 2023. The incidence of major complications is high at 25 percent, with a 1.8-percent death rate.